Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 0
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Tikcro Technologies Ltd. focuses on development of biotechnology project in Israel. It offers anti-cytotoxic T-lymphocyte-associated protein 4 for cancer immune treatment. The company was formerly known as Tioga Technologies Ltd. and changed its name to Tikcro Technologies Ltd. in September 2003. Tikcro Technologies Ltd. was founded in 1999 and is headquartered in Hadera, Israel.
Buy
Sell